Abstract
Background: Sub-clinical hypothyroidism (SCH), overt hypothyroidism and metabolic
syndrome (MetS) are recognized risk factors for atherosclerotic cardiovascular disease
and Type 2 diabetes mellitus (DM- II).Thyroid function affects MetS parameters including
blood pressure (BP), fasting blood sugar (FBS), serum triglycerides (TG) and high density
lipoprotein cholesterol (HDL-C). But the relationship between MetS and thyroid functions
is yet to be identified clearly.
The present study is to investigate the frequency of MetS in patients of SCH and overt
hypothyroidism.
Materials and Methods: A hospital based cross–sectional study was conducted
at Swastik referral laboratory and research centre. In this study, 50 patients with overt
hypothyroidism, 50 patients with SCH and 129 euthyroid controls were enrolled. National
Cholesterol Education Program- Adult Treatment Panel III (NCEP-ATP III; 2005) revision
criteria were used to diagnose metabolic syndrome. Thyroid function test (TFT: FT3, FT4
and TSH) was done by using chemiluminescence immunoassay (CLIA) and other tests
by using a semi-auto analyzer. ANalysis Of VAriance (ANOVA) test was performed using
SPSS (version 16.0).
Result: There was a significant difference in the mean of the waist circumference
(p=0.031), BP systolic (p=0.010), BP diastolic (p<0.001)), FBS (p=0.001), serum HDL-C
(p=0.031) and serum TG (p=0.003) between control, subclinical and overt hypothyroidism
group (p<0.001). Prevalence of MetS was 25.6 % in euthyroid controls whereas 44.0% in
the SCH group and 62.0% in the overt hypothyroid group (p<0.001).
Conclusion: Thyroid dysfunction may be responsible for the development of metabolic
syndrome.
References
Reaven GM. Role of insulin resistance in human disease. Diabetes. 1988 Dec 1;37(12):1595-607.
Alberti KG, Zimmet P, Shaw J. The metabolic syndrome a new worldwide definition. The Lancet. 2005 Sep 24;366 (9491):
-62.
Stern MP, Williams K, González-Villalpando C, Hunt KJ, Haffner SM. Does the metabolic syndrome improve identification of
individuals at risk of type 2 diabetes and/or cardiovascular disease? Diabetes care. 2004 Nov 1;27(11):2676-81.
Godwa V. Subclinical Thyroid dysfunction in subjects with metabolic syndrome. Journal of Biotechnology and
Biochemistry.2016;2(II):6.
Isomaa BO, Almgren P, Tuomi T, Forsén B, Lahti K, Nissen M, et al. Cardiovascular morbidity and mortality associated with the
metabolic syndrome. Diabetes care. 2001 Apr 1;24(4):683-9.
Parapid B, Ostojic MC, Lalic NM, Micic DR, Damjanovic S, Bubanja D, et al. Risk factors clustering within the metabolic
syndrome: a pattern or by chance. HJC. 2014 Apr;55(2):92-100.
Strachan MW, Walker BR. Endocrine disease. Davidson Principles and Practice of Medicine ,London.Churchill Livingstone.
nd ed.;2006:738-40.
Canaris GJ, Manowitz NR, Mayor G, Ridgway EC. The Colorado thyroid disease prevalence study. Archives of internal medicine.
Feb 28;160(4):526-34.
Surks MI, Ortiz E, Daniels GH, Sawin CT, Col NF, Cobin RH, et al. Subclinical thyroid disease: scientific review and guidelines
for diagnosis and management. JAMA . 2004 Jan 14;291(2):228-38.
Auer J, Berent R, Weber T, Lassnig E, Eber B. Thyroid function is associated with presence and severity of coronary atherosclerosis.
Clinical cardiology. 2003 Dec 1;26(12):569-73.
Tseng FY, Lin WY, Lin CC, Lee LT, Li TC, Sung PK, et al. Subclinical hypothyroidism is associated with increased risk for all-
cause and cardiovascular mortality in adults. Journal of the American College of Cardiology. 2012 Aug 21;60(8):730-7.
Kota SK, Meher LK, Krishna SV, Modi KD. Hypothyroidism in metabolic syndrome. Indian Journal of Endocrinology &
Metabolism. 2012 Dec 1;16: 332-333
Mehran L, Amouzegar A, Tohidi M, Moayedi M, Azizi F. Serum free thyroxine concentration is associated with metabolic
syndrome in euthyroid subjects. Thyroid. 2014 Nov 1;24(11):1566-74.
Baral N, Lamsal M, Koner BC, Koirala S. Thyroid dysfunction in eastern Nepal. Southeast Asian Journal of Tropical Medicine
and Public Health. 2002 Sep 16;33(3):638-41.
Uzunlulu M, Yorulmaz E, Oguz A. Prevalence of subclinical hypothyroidism in patients with metabolic syndrome. Endocrine
Journal. 2007;54(1):71-6.
Grundy SM, Cleeman JI, Daniels SR, Donato KA, Eckel RH, Franklin BA et al. Diagnosis and management of the
metabolic syndrome: An American Heart Association/National Heart, Lung, and Blood Institute scientific statement. Circulation.
Oct 25;112(17):2735-52.
Luboshitzky R, Aviv A, Herer P, Lavie L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism.
Thyroid. 2002 May 1;12(5):421-5.
Ganidagli S, ErdoganM, Kosenti A, Kulaksizoglu M, Solmaz S, Sokmen, et al. Frequency of metabolic syndrome in hypothyroid
patients. Endocrine Abstracts 2009; 20: 97,
Haque R, Ferdousi S, Ferdousi SS, Rahman W, Uddin MN, Hoque MM. Metabolic Syndrome in Hypothyroid Patients. Bangladesh
Journal of Medical Biochemistry. 2015 Feb 26;7(2):57-61.
Ruhla S, Weickert MO, Arafat AM, Osterhoff M, Isken F, Spranger J, et. al. A high normal TSH is associated with the metabolic
syndrome. Clinical Endocrinology. 2010 May 1;72(5):696-701.